Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baofukang Suppository for Aerobic Vaginitis
NCT04574089Phase 3Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- May 2020
- Primary completion
- Dec 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of baofukang shuan in Aerobic Vaginitis (AV), sponsored by Peking University Shenzhen Hospital. Started May 2020; status: recruiting.
02
Drugs
baofukang shuan
03
Conditions
Aerobic Vaginitis (AV)
Beyond the preview
Go deeper on NCT04574089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04574089.